What is Angelman Syndrome

TL;DR: Angelman syndrome is a complex genetic disorder primarily characterized by developmental delays, speech impairment, intellectual disability, and a uniquely happy, excitable demeanor. It is caused by the loss of function of the UBE3A gene on the maternal copy of chromosome 15, affecting approximately 1 in 12,000 to 20,000 individuals worldwide.

What is Angelman syndrome and how does it affect the body?

Angelman syndrome is a neuro-genetic condition that affects the nervous system, leading to significant delays in development. Individuals with Angelman syndrome typically experience severe speech impairment, often using little to no words, and may have difficulty with balance and movement, such as ataxia or jerky, tremulous limb movements. A hallmark of the condition is a distinct behavioral phenotype characterized by frequent laughter, smiling, and an easily excitable personality. Many people with Angelman syndrome also experience seizures, which typically begin before the age of three, and may have sleep disturbances or specific feeding challenges in early infancy.

What causes Angelman syndrome?

The underlying mechanism of Angelman syndrome involves the UBE3A gene, located on chromosome 15. In typical development, we inherit one copy of this gene from each parent, and both are active in most body tissues. However, in the brain, only the maternal copy is active. Angelman syndrome occurs when the maternal copy of UBE3A is missing or non-functional. There are four primary genetic mechanisms that lead to this loss of function:

• Deletion (approx. 70-75%): A segment of the maternal chromosome 15 containing the UBE3A gene is missing.


• Uniparental Disomy (approx. 3-7%): A person inherits two copies of chromosome 15 from their father and none from their mother.


• Imprinting Center Defect (approx. 2-3%): The maternal gene is present but is "silenced" or turned off due to a defect in the imprinting process.


• UBE3A Mutation (approx. 8-11%): The gene itself has a mutation that prevents it from working correctly.

How common is Angelman syndrome and who is affected?

Angelman syndrome is considered a rare disease, with prevalence estimates generally cited between 1 in 12,000 and 1 in 20,000 people. It affects both males and females equally and occurs across all ethnic and geographic populations. Because the condition is genetic, symptoms are usually noted in infancy, typically becoming more apparent between 6 and 12 months of age when developmental milestones like sitting or babbling are delayed. Within the DiseaseMaps.org community, 263 people with Angelman syndrome have shared their experiences, highlighting the importance of connecting with others navigating this journey.

What differentiates Angelman syndrome from other conditions?

Angelman syndrome is frequently misdiagnosed as cerebral palsy or autism spectrum disorder early in life due to overlapping symptoms like motor delays and communication difficulties. However, the specific combination of ataxia, microcephaly (small head size), and the characteristic "happy" demeanor often prompts clinicians to investigate the UBE3A gene. Unlike many other genetic syndromes, the specific behavioral profile—often described as having an excitable, happy temperament—is a strong clinical indicator that helps differentiate Angelman syndrome from other neurodevelopmental disorders.

Next steps

• Consult a clinical geneticist to confirm a diagnosis through specialized methylation or sequencing tests.


• Connect with the 263 members of the DiseaseMaps.org community to share experiences and find support.


• Work with a multidisciplinary team, including a pediatric neurologist, speech-language pathologist, and physical therapist, to create a personalized care plan.


• Visit the Angelman Syndrome Foundation website for the latest updates on research and clinical trials.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Angelman syndrome.


• Orphanet: Rare disease database, ORPHA:87.


• Online Mendelian Inheritance in Man (OMIM): Entry #105830.


• Angelman Syndrome Foundation (ASF): Patient education and research initiatives.